Several Helicobacter species are known to colonize the biliary tract in animals and have been identified in the gallbladder bile of a high proportion of Chilean patients with gallbladder cancer. In this study, we tried to examine the presence of Helicobacter species in the bile to know their participation in the development of extrahepatic biliary diseases. DNA was extracted from 57 bile samples from 30 patients with benign biliary diseases (cholecystolithiasis and choledochocystolithiasis), 6 malignant biliary diseases (gallbladder cancer and common bile duct cancer), and 21 nonbiliary diseases. The presence of Helicobacter genus-, H. pylori-, H. hepaticus-, and H. bilis-specific 16S rRNA genes, the H. pylori urease A gene, and the H. pylori 26K protein gene in the bile was determined by PCR and sequencing analysis. Helicobacter genus DNA (shorter amplicons, 400 bp) was statistically frequently detected in biles from 53% (16/30) and 86% (5/6) of benign and malignant biliary diseases, compared with 9% (2/21) of nonbiliary diseases, but longer amplicons (1200 bp) were not detectable in any samples. The H. pylori urease A gene (nested amplicon) was also frequently found in bile, whether benign, malignant, or control, though neither H. pylori 16S rRNA nor the 26K protein gene was detectable in any bile samples. H. bilis-16S rRNA genes were detectable in only two cases. H. hepaticus was not detectable in any samples. DNA fragments of Helicobacter species other than H. pylori, H. hepaticus, and H. bilis are commonly detectable in the bile of patients with extrahepatic biliary diseases, whether benign or malignant, implying that the Helicobacter genus may be directly or indirectly involved in the pathogenesis of these diseases.
gastric mucosa-associated lymphoid tissue lymphoma, and gastric carcinogenesis (2, 3) . Moreover, the partial DNA sequences of several Helicobacter species including H. pylori were detected in the hepatobiliary system of humans, promoting a growing interest in whether these bacteria truly colonize the hepatobiliary tract and cause hepatobiliary diseases of humans (4, 5) . A Helicobacter species inhabiting the stomach such as H. pylori, H. heilmannii, and H. felis is called a gastric Helicobacter, whereas a Helicobacter species inhabiting intestinal tracts and hepatobiliary system is referred to as an enteric Helicobacter.
So far, H. cinaedi, H. fennelliae, H. canis, H. rappini, H. pullorum, and H. canadensis have been isolated from human intestinal tracts, and various studies have been carried out on the pathogenicity of these Helicobacter species (6) .
The bacterial 16S rRNA gene, which consists of wellconserved and highly variable regions, has been identified in all bacteria, and genetic and biological distances have been defined by the homology of this rRNA gene sequence (7, 8) . That is, in contrast to phenotypic and biochemical features, the 16S rRNA sequences of a species is a stable property which is specific for the microorganism at a species level. Therefore, the genotypic identification and detection of 16S rRNA gene have been used as the best method for identifying and classifying bacteria, in conjunction with the availability of this gene in the GenBank database. Recently, the presence of DNA fragments originating from Helicobacter species has been found in the bile and gallbladder tissue of Taiwanese and Chilean patients using the polymerase chain reaction (PCR) (4, 5) , which has prompted growing interest in whether these bacteria truly colonize the biliary tract of humans and relate to the pathogenesis of hepatobiliary diseases. In contrast, several investigators failed to detect any Helicobacter DNA by PCR in German, Dutch, or Mexican patients with extrahepatic biliary disorders such as cholecystitis and common bile duct stone (7, 9, 10) .
In view of the limited and conflicting data, we investigated the presence of Helicobacter in bile samples of Japanese patients with extrahepatic biliary diseases. The aim of this study was to investigate the participation of Helicobacter species in the pathology of extrahepatic biliary diseases.
MATERIALS AND METHODS

Patients and Bile Samples
In this study, a total of 57 bile samples were aseptically obtained from 30 patients with benign extrahepatic biliary diseases (26 cholecystolithiasis and 4 choledochocystolithiasis), 6 patients with malignant extrahepatic biliary diseases (3 gallbladder cancer and 3 common bile duct cancer), and 21 patients with nonbiliary diseases used as control biles obtained from the resected gallbladder during the regular operation of gastorectomy or hepatectomy. To avoid contamination from the gastrointestinal bacterial flora, bile samples were immediately obtained by direct aspiration from cholecystectomized specimens or by the first percutaneous transhepatic cholangiodrainage from patients with obstructive jaundice. All bile samples were immediately snap-frozen in liquid nitrogen and stored at −80
• C until used. For positive controls, we used the following strains of Helicobacter: H. pylori (ATCC 43504), H. hepaticus (ATCC 51448), and H. bilis (ATCC 51630) (American Type Culture Collection, Rockville, MD). Informed consent for human bile subject research ongoing at our university, including this study, was obtained from all patients.
Bacterial Culture
All bile samples were cultured for Helicobacter species. After melting the frozen bile samples, 100-µL aliquots were incubated on Skirrow blood agar plates at 37
• C under micro-aerophilic and anaerobic conditions (GasPak system; BBL Microbiology Systems, Cockeysville, MD). Among these bile samples, eight fresh bile samples prior to freezing were also available for microaerophilic culture.
DNA Isolation from Biles
DNA was extracted using QIAamp Tissue Kits (QIAGEN, Chatworth, CA) according to modified protocol supplied by manufacture. Briefly, 200-µL bile samples were suspended in 200 µL of Buffer AL containing 20 µL of proteinase K, provided in the kit, and incubated at 70
• C for 10 min. After washing with Buffer AW2, provided in the kit, DNA samples were eluted by 200 µL distilled water (Nippon Gene, Tokyo). Five microliters of the extracted DNA sample was used as a template for PCR.
PCR Amplification
Helicobacter Genus-Specific PCR. Helicobacter-specific primer pairs C97 and C98 or C97 and C05 were used to generate 16S ribosomal RNA (rRNA) gene amplicons of approximately 400 bp or 1200 bp, respectively (Table 1) (4). The extracted DNA sample was added to a 25-µL (final volume) reaction mixture containing 0.2 mM dNTPs, a 1 µM concentration of each of the sense and antisense primers, 5 units of Takara EX Taq DNA polymerase, and the supplied 1X PCR buffer (Takara, Tokyo). The following conditions were used for amplification: initial denaturation at 94
• C for 4 min, denaturation at 94
• C for 1 min, annealing at 55
• C for 2.5 min, and elongation at 72 • C for 3 min. A total of 40 cycles was preformed, followed by a final elongation step of 5 min at 72
• C. H. pylori Urease A Gene-Specific PCR. A two-step PCR (nested PCR) was performed with two pairs of primers to detect the H. pylori urease A gene, as described by Lin et al. (5) ( Table 1 ). The first step entailed amplification at 94
• C for 1 min, 50
• C for 2 min, and 72
• C for 1 min for 35 cycles. The second step was performed using 1 µL of the PCR products of the first reaction according to the same programmed for 40 cycles.
Helicobacter Species-Specific PCR. Samples generating a positive result in Helicobacter genus-specific PCR were subsequently analyzed with four different pairs of primers corresponding to genes encoded for H. pylori 16S rRNA and 26K protein, H. hepaticus 16S rRNA, and H. bilis 16S rRNA (Table 1 ) (8, (11) (12) (13) . The following conditions were used for each amplification: 94
• C/1 min, 53
• C/1.5 min, and 72
• C/1 min for 40 cycles for the H. pylori 16S rRNA and 26K protein gene; 94
• C/1 min, 60
• C/2 min, and 72
• C/2 min for 40 cycles for the H. hepaticus 16S rRNA gene; and 94
• C/1 min, 55
• C/2.5 min for 40 cycles for the H. bilis 16S rRNA gene. Five microliters of the PCR products was electrophoretically separated in a 1% agarose gel containing ethidium bromide and visualized with UV light. For extraction of DNA and preparation of the PCR solution, distilled water was used. No band was constantly obtained when the extracted DNA sample was replaced by distilled water as a negative control. Next, to assess the detection sensitivity of this PCR system for the Helicobacter genus 16S rRNA gene, the following studies were performed. We harvested H. pylori, H. hepaticus, and H. bilis and extracted and quantified bacterial DNA. We then used the amount of 100 pg bacterial DNA and their serial dilutions as a template for the PCR. Consequently, the sensitivity of the PCR assay utilized in this study was as follows: Helicobacter genus (short PCR; 1 pg), Helicobacter genus (long PCR; 10 pg), H. pylori urease A gene (nested PCR; 100 fg), H. pylori 16S rRNA (10 pg), H. pylori 26K protein (1 pg), H. hepaticus 16S rRNA (1 pg), and H. bilis 16S rRNA (10 pg).
Direct Sequencing and Sequence Analysis
The nucleotide sequence of amplified PCR products was determined to confirm the predicted sequence by direct sequencing using the Big Dye Terminator Cycle Sequencing Kit and ABI Prism 377 DNA sequencer (Applied Biosystems, Tokyo). Then the sequence similarity search was done using the analyzing tool on the Internet database (BLAST; http://blast.genome.jp/).
Statistical Analysis
Data were analyzed using Fisher's exact probability test. P < 0.05 was considered statistically significant.
RESULTS
Culture
Despite prolonged incubation for up to 2 weeks, any Helicobacter species were not cultured from the meltedfrozen bile samples under micro-aerobic or anaerobic conditions and from the fresh bile samples under microaerobic conditions, though H. pylori, H. hepaticus, and H. bilis used as positive controls were well-grown under the same conditions.
Detection of the Helicobacter Genus 16S rRNA Gene
The analysis of all 57 bile samples by PCR amplification using C97 and C98 primers (shorter amplicon; approximately 400 bp) demonstrated the presence of the Helicobacter genus 16S rRNA gene in 23 of 57 (40%) bile samples including 16 of 30 (53%) in benign biliary diseases (12 cholecystolithiasis and 4 choledochocystolithiasis), 5 of 6 (86%) in malignant biliary diseases (2 gallbladder cancer and 3 common bile duct cancer), and 2 of 21 (9%) in nonbiliary diseases (controls) ( Table 2 ). Moreover, we check the amplified PCR products by direct sequencing and BLAST search and confirmed that each sequence was 95-97% similar to a known Helicobacter genus registered in GenBank. However, longer amplicons (approximately 1200 bp) using C97 and C05 were not detected in any bile samples (Table 2) , while longer amplicons were constantly detected in positive controls. 
Detection of the Urease A Gene
Among 57 bile samples, 12 (21%) samples were amplified for urease A by the first of nested PCR (Table 3 ). These were 6 of 30 (19%) bile samples in benign biliary diseases (5 cholecystolithiasis and 1 choledochocystolithiasis), 1 of 6 (17%) in malignant biliary diseases (common bile duct cancer), and 5 of 21 (24%) in nonbiliary diseases. Nested PCR revealed its presence in 31 of 57 (54%) bile samples: 17 of 30 (56%) in benign biliary disease (14 cholecystolithiasis and 3 choledocholithiasis), 2 of 6 (33%) in malignant biliary disease (2 common bile duct cancer), and 12 of 21 (57%) in nonbiliary diseases (Table 3 ). All bile samples positive for first-step amplicon were also positive for the nested PCR. Sequence analysis of these nested PCR products revealed that each sequence was 90-95% similar to a known H. pylori urease A gene.
Detection of Helicobacter Species-Specific Genes
Twenty-three bile samples generating positive results in Helicobacter genus-specific PCR using C97 and C98 primers (shorter amplicon) were subsequently analyzed for the H. pylori 16S rRNA and 26K protein genes, H. hepaticus 16S rRNA gene, and H. bilis 16S rRNA gene. Consequently, PCR for the H. pylori 16S rRNA and 26K protein genes failed the amplification in any bile samples ( 16S rRNA genes, one bile sample (cholecystolithiasis) and two samples (choledochocystolithiasis and common bile duct cancer) were positive, respectively (Table 4) . A distinct amplicon was visualized in each positive control by the PCR performed at the same time. By direct sequencing and BLAST search for these amplified PCR products, two amplicons amplified by H. bilis-specific PCR were confirmed to be more than 95% similar to the H. bilis sequence, but one amplicon amplified by H. hepaticusspecific PCR was not the H. hepaticus gene.
DISCUSSION
There have been several reports to support a causeand-effect association between infection with Helicobacter species and hepatobiliary diseases in human. Fox et al. (4) identified Helicobacter species including H. bilis, Flexispira rappini, and H. pullorum in bile and excised gallbladder samples from 46 Chilean patients with chronic cholecystitis. In addition, H. pylori or closely similar H. pylori has been reported to be detected in liver tissue from patients with cholestatic liver diseases such as primary sclerosing cholangitis, suggesting that Helicobacter might contribute to the development and/or the pathogenesis of chronic cholangitis (13) . Since then, in reports concerning the participation of Helicobacter species in hepatobiliary diseases, the existence of DNA fragments from some Helicobacter species including H. pylori have been demonstrated in the bile, gall bladder, or liver tissue using the PCR technique and genotypic identification, though cultural studies for these bacteria gave negative results (4, (13) (14) (15) (16) (17) . However, there have been other reports that no Helicobacter species were detected in bile samples by the PCR method (7, 9, 10, 18) . These inconsistencies may be due to differences in sensitivity of PCR and primers or to geographical and regional variations of hepatobiliary diseases and their etiologies.
In view of the limited and conflicting data on this issue, we performed bacterial cultivation and genotypic identification studies to detect and identify Helicobacter species in bile from Japanese patients with benign and malignant biliary diseases and 21 with nonbiliary diseases. PCR study using primers for the Helicobacter genusspecific 16S rRNA gene disclosed that Helicobacter DNA (shorter amplicons; 400 bp) was frequently detected in the bile of patients with benign and also malignant biliary diseases, compared with nonbiliary diseases, suggesting that the Helicobacter genus participates directly or indirectly in the pathogenesis of extrahepatic biliary diseases. However, the growth of Helicobacter species was not shown by suitable culture of bile samples, suggesting that these bacteria are dead or uncultivable coccoid forms of Helicobacter. Furthermore, a longer amplicon (1200 bp) of Helicobacter DNA was not detected in any bile samples by PCR. This discrepancy between short and long PCR may be due to differences in sensitivity of these PCR assays or may suggest that Helicobacter species detectable in the bile are present as fragmented bacterial components.
In 1995, Lin et al. (5) first demonstrated the presence of the H. pylori urease A gene in three bile samples from patients with advanced gastric cancer and pancreatic head cancer by nested PCR using two sets of primers for the H. pylori urease A gene. In addition, Kawaguchi et al. (19) reported a 41-year-old woman in whom the presence of H. pylori was shown in the gallbladder epithelium by both PCR and immunohistochemistry for H. pylori urease B. It was found in this study that the H. pylori urease A gene was detected in the bile by single and nested PCR using primers specific for the H. pylori urease A gene (5), though there was not a statistical significance in the detection rate of the H. pylori urease A gene among benign and malignant biliary diseases and controls. The urease A gene is known to cross-react with the urease gene of other organisms, and sequences for only a few of the Helicobacter species have been determined. Therefore, because PCR results based on the urease A gene may give a false-positive result in the detection of H. pylori (20) , the possibility of the presence of bacteria other than H. pylori can not be excluded. In addition, sequencing of these PCR products revealed that each sequence was only 90-95% similar to a known H. pylori urease A gene, suggesting the presence of unknown urease genes closely resembling the H. pylori urease A gene in bile examined in this study.
Then we performed a species identification by PCR using primers specific for two kinds of H. pylori genes (16S rRNA and 26K protein) to examine whether or not Helicobacter species detected by Helicobacter genusspecific PCR were H. pylori. It was found in this study that neither the H. pylori 16S rRNA gene nor the 26K protein gene could be detected in any bile examined. Instead, we detected H. bilis 16S rRNA genes by this specific PCR in one case of cholecystolithiasis and in one case of common bile duct cancer. Although H. hepaticus was detected in one bile sample of cholecystolithiasis by PCR, sequencing analysis revealed that this amplicon was not the H. hepaticus-specific 16S rRNA gene. Taken together, most amplicons shown by Helicobacter genus-specific PCR in the bile of benign and malignant biliary diseases in this study might have originated from Helicobacter species other than H. pylori, H. hepaticus, and H. bilis. Unfortunately, we could not get further information on the classification of these Helicobacter species in the bile.
Because of the toxicity of deoxycholic acid and chenodeoxycholic acid, consisting of major ingredients of bile, most bacteria barely survive and proliferate in bile. Some Helicobacter species, however, show bile tolerance, and colonization of bile acid-tolerant Helicobacter species in the liver of experimental animals was reported (21) (22) (23) (24) . Especially, in an animal experiment on mouse, H. hepaticus and H. bilis were isolated and cultivated from bile and liver tissue, which has been noted as a causative factor of chronic active hepatitis and hepatic neoplasm (21) (22) (23) (24) . In this study, we infrequently detected H. bilis genes in bile, but their pathogenetic roles in human bile and in the biliary tree are still unknown.
Our recent study disclosed that biliary epithelial cells (BEC) are able to express several Toll-like receptors (TLR) such as TLR2 and TLR4, which belong to cell surface receptors and transduce intracellular signals in response to living or dead microorganisms and pathogen-associated molecular patterns (PAMPs) (25) . The results obtained in this study suggest that the fragmented bacterial components including bacterial DNA, ligands for TLRs, in the bile, may cause aberrant expression of adhesion molecules and secretion of proinflammatory cytokines in BEC following TLR-ligand interaction and then lead to inflammatory biliary diseases. This may finally lead to the development of cholangiocarcinoma. In this sense, the Helicobacter species DNA found in the bile may be responsible for the induction and development of inflammatory and neoplastic biliary diseases.
In conclusion, our study revealed that DNA fragments originating from Helicobacter species other than H. pylori, H. hepaticus, and H. bilis are commonly detectable in the bile of patients with extrahepatic biliary diseases, whether benign or malignant. It seems unlikely that Helicobacter species exist alive in the bile and/or infect the biliary tree as live bacteria. We infer from this fact that Helicobacter species are responsible for the pathogenesis of chronic biliary inflammation and further biliary carcinogenesis. Further studies are necessary to evaluate the pathogenic roles of Helicobacter species with respect to hepatobiliary diseases.
